Showing results (91-100 of 322) with videos related to
Sort By:
Pageof 33
Genetics|January 5, 1999
Complexity of developmental control: analysis of embryonic cell lineage specification in Caenorhabditis elegans using pes-1 as an early markerL Molin, H Schnabel, T Kaletta, et al.Survey of Immunologic Research|January 1, 1985
Thymopentin treatment in AIDS and pre-AIDS patientsN Clumeck, S Cran, P Van de Perre, et al.Archives of Dermatology|March 1, 1976
Clofazimine. A new agent for the treatment of pyoderma gangrenosumG Michaëlsson, L Molin, S Ohmann, et al.Cutis|February 1, 1980
Aspects of the treatment of mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Study GroupL Molin, K Thomsen, G Volden, et al.The British Journal of Dermatology|June 20, 2002
Quality of life in 6497 Nordic patients with psoriasisR Zachariae, H Zachariae, K Blomqvist, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2003
Self-reported stress reactivity and psoriasis-related stress of Nordic psoriasis sufferersR Zachariae, H Zachariae, K Blomqvist, et al.Acta Dermato-Venereologica|August 15, 2001
Treatment of psoriasis in the Nordic countries: a questionnaire survey from 5739 members of the psoriasis associations data from the Nordic Quality of Life StudyH Zachariae, R Zachariae, K Blomqvist, et al.Acta Dermato-Venereologica|January 1, 1987
Retinoids and systemic chemotherapy in cases of advanced mycosis fungoides. A report from the Scandinavian Mycosis Fungoides GroupL Molin, K Thomsen, G Volden, et al.International Journal of Clinical Pharmacology Research|January 1, 1984
Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritisM Malaise, P Franchimont, C Hauwaert, et al.Survey of Immunologic Research|January 1, 1985
Confirmative study of the effectiveness of thymopentin in active rheumatoid arthritisM Malaise, P Franchimont, C Hauwaert, et al.Pageof 33